Safety and Dosimetry of 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Lutetium (177Lu) vipivotide tetraxetan (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; First in man
Most Recent Events
- 14 Jun 2019 New trial record